CELLTech™
CELLTech™ Stroke
CELLTech™ is a deep brain stimulation platform that aims to improve motor function in patients with permanent, moderate to severe disability due to subcortical ischemic stroke. CELLTech™ DBS requires the same surgical procedure as the FDA-approved deep brain stimulator and as other DBS systems, applies microcurrents directly to brain tissue.
The proprietary CELLTech™ waveform has been carefully studied, designed and implemented for use in enhancing the natural reparative mechanism that is utilized in the brain post-stroke during a process known as spontaneous regeneration.
The CELLTech™ Advantage
The field of medicine has been trending towards a more diverse and balanced approach to patient care. This includes R&D efforts to market approve sustainable and patient-centered solutions that optimize safety and efficacy.
CELLTech™ consists only of hardware and software, and therefore is scalable and easily standardized.
Next Generation Deep Brain Stimulation
CELLTech™ aims to give every patient back the quality of life and independence they have lost due to neurological tissue damage. While CELLTech™ has been designed and is pending clinical testing for use in treating motor function loss after stroke, additional indications are possible once market-approved for this first use.
CELLTech™ Stroke
CELLTech™ is a deep brain stimulation platform that aims to improve motor function in patients with permanent, moderate to severe disability due to subcortical ischemic stroke. CELLTech™ DBS requires the same surgical procedure as the FDA-approved deep brain stimulator and as other DBS systems, applies microcurrents directly to brain tissue.
The proprietary CELLTech™ waveform has been carefully studied, designed and implemented for use in enhancing the natural reparative mechanism that is utilized in the brain post-stroke during a process known as spontaneous regeneration.
The CELLTech™ Advantage
The field of medicine has been trending towards a more diverse and balanced approach to patient care. This includes R&D efforts to market approve sustainable and patient-centered solutions that optimize safety and efficacy.
CELLTech™ consists only of hardware and software, and therefore is scalable and easily standardized.
Next Generation Deep Brain Stimulation
CELLTech™ aims to give every patient back the quality of life and independence they have lost due to neurological tissue damage. While CELLTech™ has been designed and is pending clinical testing for use in treating motor function loss after stroke, additional indications are possible once market-approved for this first use.